Julia M. Loudon

SB 202026: A Novel Muscarinic Partial Agonist with Functional Selectivity for M1 Receptors

Julia M. Loudon, Steven M. Bromidge, Frank Brown et al. · Journal of Pharmacology and Experimental Therapeutics · 1997 · 47 citations

Design of [<i>R</i>-(<i>Z</i>)]-(+)-α-(Methoxyimino)-1-azabicyclo[2.2.2]octane-3-acetonitrile (SB 202026), a Functionally Selective Azabicyclic Muscarinic M1 Agonist Incorporating the <i>N</i>-Methoxy Imidoyl Nitrile Group as a Novel Ester Bioisostere

Steven M. Bromidge, Frank Brown, Frederick Cassidy et al. · Journal of Medicinal Chemistry · 1997 · 30 citations · Full text

Organic Chemistry, Pharmacotherapy, Heterocycle Chemistry +23

Albumin Metabolism in Elderly Patients

Dawn P. Misra, Julia M. Loudon, G.E. Staddon · Journal of Gerontology · 1975 · 28 citations

Plasma Albumin, Electrolyte Disorder, Aging +17

Sabcomeline (SB-202026), a functionally selective M 1 receptor partial agonist, reverses delay-induced deficits in the T-maze

John Hatcher, Julia M. Loudon, Jim J. Hagan et al. · Psychopharmacology · 1998 · 22 citations

Molecular Pharmacology, Receptor Partial Agonist, Functional Selectivity +9

A novel and selective class of azabicyclic muscarinic agonists incorporating an N-methoxy imidoyl halide or nitrile functionality

Steven M. Bromidge, Frank Brown, Frederick Cassidy et al. · Bioorganic & Medicinal Chemistry Letters · 1992 · 19 citations

Nitrile Functionality, Medicine, Mechanism Of Action +9